Skip to the page

Data / Form D filings / Alphina Therapeutics, Inc.

Alphina Therapeutics, Inc.: Form D filings

Alphina Therapeutics, Inc., a biotechnology company in New Haven, CT, filed 2 Form D notices with the SEC between 2021 and 2026. The latest, on March 16, 2026, reports $153,715 sold of a $10 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
55 Church Street, New Haven, CT, 06510
Phone
(650) 438-8738
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1882991

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 16, 2026New notice$10,000,000$153,715$9,846,2853Feb 23, 2026sec.gov
Sep 15, 2021New notice$39,999,997$16,851,590$23,148,40719Sep 7, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Nicholas J GalliExecutive Officer, Director
Ranjit BindraDirector
Kevin RakinDirector
Colleen CuffaroDirector
Barbara FoxExecutive Officer, Director
Matthew CohenDirector

Other biotechnology companies in Connecticut that filed recently

Every Form D from the week of Mar 16, 2026 · All recent filings in Connecticut · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Alphina Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.